TRIM2 and sarcopenia: Recently, a human patient with a heterozygous missense mutation in TRIM2 was reported to exhibit a loss of gross motor neuron development that resulted in an early onset of axonal neuropathy, muscle hypotonia, and sarcopenia [9].